Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease

This record (Policy ID A54927) is titled 'Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease' but the substantive policy content was not provided. No specific indications, limitations, documentation requirements, or frequency limits could be extracted from the supplied text; manual review of the full policy document is required to populate structured criteria.

"Policy text not provided; unable to extract specific covered indications for genetic testing for BCR-ABL-negative myeloproliferative disease from the supplied document."

Sign up to see full coverage criteria, indications, and limitations.